keyword
MENU ▼
Read by QxMD icon Read
search

Dipak kotecha

keyword
https://www.readbyqxmd.com/read/28467883/heart-rate-heart-rhythm-and-prognostic-benefits-of-beta-blockers-in-heart-failure-individual-patient-data-meta-analysis
#1
Dipak Kotecha, Marcus D Flather, Douglas G Altman, Jane Holmes, Giuseppe Rosano, John Wikstrand, Milton Packer, Andrew J S Coats, Luis Manzano, Michael Böhm, Dirk J van Veldhuisen, Bert Andersson, Hans Wedel, Thomas G von Lueder, Alan S Rigby, Åke Hjalmarson, John Kjekshus, John G F Cleland
BACKGROUND: The relationship between mortality and heart rate remains unclear for patients with heart failure and reduced ejection fraction (HFrEF) in either sinus rhythm or atrial fibrillation (AF). OBJECTIVE: To investigate the prognostic importance of heart rate in HFrEF in randomized controlled trials (RCTs) comparing beta-blockers and placebo. METHODS: The Beta-blockers in Heart Failure Collaborative Group performed a meta-analysis of harmonized individual-patient data from eleven double-blind RCTs...
April 5, 2017: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/28455344/temporal-trends-in-incidence-prevalence-and-mortality-of-atrial-fibrillation-in-primary-care
#2
Deirdre A Lane, Flemming Skjøth, Gregory Y H Lip, Torben B Larsen, Dipak Kotecha
BACKGROUND: Incidence and prevalence of atrial fibrillation (AF) are expected to increase dramatically; however, we currently lack comprehensive data on temporal trends in unselected clinical populations. METHODS AND RESULTS: Analysis of the UK Clinical Practice Research Datalink (CPRD) from 1998 to 2010 of patients with incident AF, excluding major valvular disease, linked to hospital admission data and national statistics. Fifty-seven thousand eight hundred eighteen adults were identified with mean age 74...
April 28, 2017: Journal of the American Heart Association
https://www.readbyqxmd.com/read/28387802/is-echocardiography-valid-and-reproducible-in-patients-with-atrial-fibrillation-a-systematic-review
#3
Dipak Kotecha, Mohamed Mohamed, Eduard Shantsila, Bogdan A Popescu, Richard P Steeds
Aims: Echocardiography is vital in the routine assessment and management of atrial fibrillation (AF). We performed a systematic review of the validity and reproducibility of echocardiographic left ventricular systolic and diastolic function in AF, and optimal acquisition methods. Methods and results: Online databases were searched for studies in patients with AF at the time of echocardiography (1960 to August 2015), prospectively registered with PROSPERO (CRD42015025297)...
April 6, 2017: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/28228467/gender-differences-in-clinical-presentation-and-1-year-outcomes-in-atrial-fibrillation
#4
Renate B Schnabel, Ladislav Pecen, Francisco M Ojeda, Markus Lucerna, Nargiz Rzayeva, Stefan Blankenberg, Harald Darius, Dipak Kotecha, Raffaele De Caterina, Paulus Kirchhof
OBJECTIVES: Our objective was to examine gender differences in clinical presentation, management and prognosis of atrial fibrillation (AF) in a contemporary cohort. METHODS: In 6412 patients, 39.7% women, of the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation, we examined gender differences in symptoms, risk factors, therapies and 1-year incidence of adverse outcomes. RESULTS: Men with AF were on average younger than women (mean±SD: 70...
July 2017: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/28038729/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#5
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castellá, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas
No abstract text is available yet for this article.
January 2017: Revista Española de Cardiología
https://www.readbyqxmd.com/read/28009037/-2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#6
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas
No abstract text is available yet for this article.
2016: Kardiologia Polska
https://www.readbyqxmd.com/read/27855811/heart-failure-with-preserved-ejection%C3%A2-fraction-and%C3%A2-atrial-fibrillation-vicious-twins
#7
REVIEW
Dipak Kotecha, Carolyn S P Lam, Dirk J Van Veldhuisen, Isabelle C Van Gelder, Adriaan A Voors, Michiel Rienstra
Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are age-related conditions that are increasing in prevalence, commonly coexist, and share clinical features. This review provides a practical update on the epidemiology, pathophysiology, diagnosis, and management of patients with concomitant HFpEF and AF. Epidemiological studies highlight the close and complex links between HFpEF and AF, the shared risk factors, the high AF occurrence in the natural history of HFpEF, and the independent contribution of each condition to poor outcomes...
November 15, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27802324/patient-reported-outcomes-for-quality-of-life-assessment-in-atrial-fibrillation-a-systematic-review-of-measurement-properties
#8
REVIEW
Dipak Kotecha, Amar Ahmed, Melanie Calvert, Mauro Lencioni, Caroline B Terwee, Deirdre A Lane
BACKGROUND: Atrial fibrillation is a large and growing burden across all types of healthcare. Both incidence and prevalence are expected to double in the next 20 years, with huge impact on hospital admissions, costs and patient quality of life. Patient wellbeing determines the management strategy for atrial fibrillation, including the use of rhythm control therapy and the clinical success of heart rate control. Hence, evaluation of quality of life is an emerging and important part of the assessment of patients with atrial fibrillation...
2016: PloS One
https://www.readbyqxmd.com/read/27663299/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#9
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas, Stefan Agewall, John Camm, Gonzalo Baron Esquivias, Werner Budts, Scipione Carerj, Filip Casselman, Antonio Coca, Raffaele De Caterina, Spiridon Deftereos, Dobromir Dobrev, José M Ferro, Gerasimos Filippatos, Donna Fitzsimons, Bulent Gorenek, Maxine Guenoun, Stefan H Hohnloser, Philippe Kolh, Gregory Y H Lip, Athanasios Manolis, John McMurray, Piotr Ponikowski, Raphael Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Luis Tamargo, Clare J Taylor, Isabelle C Van Gelder, Adriaan A Voors, Stephan Windecker, Jose Luis Zamorano, Katja Zeppenfeld
No abstract text is available yet for this article.
November 2016: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/27609819/echocardiographic-structure-and-function-in-hypertensive-disorders-of-pregnancy-a-systematic-review
#10
REVIEW
James S Castleman, Ramesh Ganapathy, Fatima Taki, Gregory Y H Lip, Richard P Steeds, Dipak Kotecha
BACKGROUND: Echocardiography is commonly used to direct the management of hypertensive disorders in medical patients, but its application in pregnancy is unclear. Our objective was to define the use of echocardiography in pregnancies complicated by gestational hypertension (GH) and preeclampsia. METHODS AND RESULTS: We performed a systematic review of articles using an electronic search of databases from inception to March 2015, prospectively registered with PROSPERO (CRD42015015700)...
September 2016: Circulation. Cardiovascular Imaging
https://www.readbyqxmd.com/read/27586233/magnesium-for-atrial-fibrillation-myth-or-magic
#11
EDITORIAL
Dipak Kotecha
No abstract text is available yet for this article.
September 2016: Circulation. Arrhythmia and Electrophysiology
https://www.readbyqxmd.com/read/27567465/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#12
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas, Stefan Agewall, John Camm, Gonzalo Baron Esquivias, Werner Budts, Scipione Carerj, Filip Casselman, Antonio Coca, Raffaele De Caterina, Spiridon Deftereos, Dobromir Dobrev, José M Ferro, Gerasimos Filippatos, Donna Fitzsimons, Bulent Gorenek, Maxine Guenoun, Stefan H Hohnloser, Philippe Kolh, Gregory Y H Lip, Athanasios Manolis, John McMurray, Piotr Ponikowski, Raphael Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Luis Tamargo, Clare J Taylor, Isabelle C Van Gelder, Adriaan A Voors, Stephan Windecker, Jose Luis Zamorano, Katja Zeppenfeld
No abstract text is available yet for this article.
November 2016: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/27567408/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#13
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castella, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas, Stefan Agewall, John Camm, Gonzalo Baron Esquivias, Werner Budts, Scipione Carerj, Filip Casselman, Antonio Coca, Raffaele De Caterina, Spiridon Deftereos, Dobromir Dobrev, José M Ferro, Gerasimos Filippatos, Donna Fitzsimons, Bulent Gorenek, Maxine Guenoun, Stefan H Hohnloser, Philippe Kolh, Gregory Y H Lip, Athanasios Manolis, John McMurray, Piotr Ponikowski, Raphael Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Luis Tamargo, Clare J Taylor, Isabelle C Van Gelder, Adriaan A Voors, Stephan Windecker, Jose Luis Zamorano, Katja Zeppenfeld
No abstract text is available yet for this article.
October 7, 2016: European Heart Journal
https://www.readbyqxmd.com/read/27156593/digoxin-the-good-and-the-bad
#14
REVIEW
Oliver J Ziff, Dipak Kotecha
After 230 years of use, digitalis remains an important and useful therapy for patients with atrial fibrillation, heart failure, and the 30-50 % of patients with both conditions. Although the combination of positive inotropic activity with negative chronotropic effects has been shown to reduce hospital admissions in heart failure, there is a distinct lack of robust trial data, particularly in patients with atrial fibrillation. We recently performed a comprehensive meta-analysis of all digoxin studies and demonstrated a neutral effect on mortality...
October 2016: Trends in Cardiovascular Medicine
https://www.readbyqxmd.com/read/27098105/effect-of-age-and-sex-on-efficacy-and-tolerability-of-%C3%AE-blockers-in-patients-with-heart-failure-with-reduced-ejection-fraction-individual-patient-data-meta-analysis
#15
REVIEW
Dipak Kotecha, Luis Manzano, Henry Krum, Giuseppe Rosano, Jane Holmes, Douglas G Altman, Peter D Collins, Milton Packer, John Wikstrand, Andrew J S Coats, John G F Cleland, Paulus Kirchhof, Thomas G von Lueder, Alan S Rigby, Bert Andersson, Gregory Y H Lip, Dirk J van Veldhuisen, Marcelo C Shibata, Hans Wedel, Michael Böhm, Marcus D Flather
OBJECTIVES: To determine the efficacy and tolerability of β blockers in a broad age range of women and men with heart failure with reduced ejection fraction (HFrEF) by pooling individual patient data from placebo controlled randomised trials. DESIGN: Prospectively designed meta-analysis of individual patient data from patients aged 40-85 in sinus rhythm at baseline, with left ventricular ejection fraction <0.45. PARTICIPANTS: 13,833 patients from 11 trials; median age 64; 24% women...
April 20, 2016: BMJ: British Medical Journal
https://www.readbyqxmd.com/read/27087520/letter-conflicting-and-unresolved-issue-of-the-prognostic-value-of-atrial-fibrillation-for-chronic-heart-failure-patients-response
#16
Dipak Kotecha
No abstract text is available yet for this article.
July 1, 2016: International Journal of Cardiology
https://www.readbyqxmd.com/read/26950607/in-memoriam-henry-krum-1958-2015
#17
Thomas G von Lueder, Ingrid Hopper, Dipak Kotecha, Dan Atar
No abstract text is available yet for this article.
2016: Cardiology
https://www.readbyqxmd.com/read/26829930/comorbidities-in-heart-failure-are-there-gender-differences
#18
REVIEW
Ingrid Hopper, Dipak Kotecha, Ken Lee Chin, Robert J Mentz, Thomas G von Lueder
Compared to men, women with heart failure (HF) are often older, smoke less, and have more preserved ejection fraction (EF) and hypertensive HF rather than HF of ischemic etiology. Gender-stratified outcomes on comorbidities data in HF are scarce. Women have traditionally been underrepresented in HF trials. Although data suggest that overall prognosis may be better in women, they experience lower quality of life with greater functional impairment from HF compared to men. Gender differences have been reported for comorbid diabetes, chronic obstructive pulmonary disease, renal dysfunction, anemia, and depression and may explain gender disparity in outcomes...
February 2016: Current Heart Failure Reports
https://www.readbyqxmd.com/read/26580351/atrial-fibrillation-and-heart-failure-due-to-reduced-versus-preserved-ejection-fraction-a-systematic-review-and-meta-analysis-of-death-and-adverse-outcomes
#19
REVIEW
Dipak Kotecha, Rajiv Chudasama, Deirdre A Lane, Paulus Kirchhof, Gregory Y H Lip
BACKGROUND: Atrial fibrillation (AF) and heart failure frequently coexist, commonly resulting in serious adverse events. With both conditions increasing in prevalence and justified concerns about treatment efficacy, it is vital to understand how the type of heart failure impacts on prognosis. METHODS: We performed a systematic review of studies examining cardiovascular outcomes in AF patients with heart failure and reduced ejection fraction (AF-HFrEF) compared to those with preserved ejection fraction (AF-HFpEF)...
January 15, 2016: International Journal of Cardiology
https://www.readbyqxmd.com/read/26481149/a-roadmap-to-improve-the-quality-of-atrial-fibrillation-management-proceedings-from-the-fifth-atrial-fibrillation-network-european-heart-rhythm-association-consensus-conference
#20
REVIEW
Paulus Kirchhof, Günter Breithardt, Jeroen Bax, Gerlinde Benninger, Carina Blomstrom-Lundqvist, Giuseppe Boriani, Axel Brandes, Helen Brown, Martina Brueckmann, Hugh Calkins, Melanie Calvert, Vincent Christoffels, Harry Crijns, Dobromir Dobrev, Patrick Ellinor, Larissa Fabritz, Thomas Fetsch, S Ben Freedman, Andrea Gerth, Andreas Goette, Eduard Guasch, Guido Hack, Laurent Haegeli, Stephane Hatem, Karl Georg Haeusler, Hein Heidbüchel, Jutta Heinrich-Nols, Francoise Hidden-Lucet, Gerd Hindricks, Steen Juul-Möller, Stefan Kääb, Lukas Kappenberger, Stefanie Kespohl, Dipak Kotecha, Deirdre A Lane, Angelika Leute, Thorsten Lewalter, Ralf Meyer, Lluis Mont, Felix Münzel, Michael Nabauer, Jens C Nielsen, Michael Oeff, Jonas Oldgren, Ali Oto, Jonathan P Piccini, Art Pilmeyer, Tatjana Potpara, Ursula Ravens, Holger Reinecke, Thomas Rostock, Joerg Rustige, Irene Savelieva, Renate Schnabel, Ulrich Schotten, Lars Schwichtenberg, Moritz F Sinner, Gerhard Steinbeck, Monika Stoll, Luigi Tavazzi, Sakis Themistoclakis, Hung Fat Tse, Isabelle C Van Gelder, Panagiotis E Vardas, Timo Varpula, Alphons Vincent, David Werring, Stephan Willems, André Ziegler, Gregory Y H Lip, A John Camm
At least 30 million people worldwide carry a diagnosis of atrial fibrillation (AF), and many more suffer from undiagnosed, subclinical, or 'silent' AF. Atrial fibrillation-related cardiovascular mortality and morbidity, including cardiovascular deaths, heart failure, stroke, and hospitalizations, remain unacceptably high, even when evidence-based therapies such as anticoagulation and rate control are used. Furthermore, it is still necessary to define how best to prevent AF, largely due to a lack of clinical measures that would allow identification of treatable causes of AF in any given patient...
January 2016: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
keyword
keyword
108098
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"